Two companies will invest combined $34.4M in St. Joseph facilities

Boehringer Ingelheim Corp., a company in the Kansas City Animal Health Corridor, and LifeLine Foods, a corn processor, have committed to investing a combined $34.4 million in life sciences in St. Joseph. Boehringer Ingelheim will invest about $22.4 million to increase its capacity to manufacture vaccines for livestock at its St. Joseph campus. On Monday, the St. Joseph City Council will consider granting Chapter 100 sale-leaseback incentives. The project also will receive incentives from the KCP&L …
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news